Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT04914182
Other study ID # LASER
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date June 3, 2021
Est. completion date October 2024

Study information

Verified date May 2023
Source Instituto Materno Infantil Prof. Fernando Figueira
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Scenario: spontaneous perineal laceration is an injury to the tissue in the perineum region, which can occur during vaginal delivery. The lesion can be classified into four degrees, according to the structures affected, with degrees one and two being more common. Some consequences may arise due to lacerations, such as perineal pain, genito-pelvic pain, in addition to infection, and dehiscence of the lesion, which may last up to one year after delivery. A laser is a form of non-ionizing radiation and when used in the repair process it is capable of generating analgesic, anti-inflammatory, and healing effects. Low-level laser treatment has been used in several areas, promoting cellular and vascular responses capable of accelerating the repair of injured tissue, in addition to pain relief and consequently capable of improving patients' quality of life. Objective: To determine the effects of low-power laser on the acceleration of the healing process and pain relief in primiparous women who had a spontaneous perineal tear, grade one and two, during normal delivery. Methods: a pilot randomized clinical trial will be carried out. Two groups will be divided randomly, one group will receive the application of the laser, and the second group the laser "sham". Data collection will be carried out at the LAbor and delivery rooms of the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP). Primiparous women who had a spontaneous perineal tear, grades one and two, over 18 years of age or younger who are in charge, with a full-term pregnancy, single fetus, cephalic presentation, and who have been admitted to labor at the ANC will be included, excluding patients who are transferred to another sector, those that evolve to a cesarean section or need episiotomy or curettage and, in addition, the presence of infection during childbirth assistance, postpartum hemorrhage and suspected or diagnosed COVID-19. The laser will be applied at three predetermined moments: six hours, 24, and 48 hours after delivery. To evaluate the healing process a REEDA scale and a Peri-rule will be used. The assessment of pain intensity will be through the Visual Analogue Scale (VAS). Ethical Aspects: the research will be submitted to the IMIP Research Ethics Committee and data collection will begin after its approval. All data will be kept confidential and confidential, the participant will be asked to sign the Informed Consent Form before beginning any procedure.


Description:

In primiparous women with spontaneous perineal laceration, grade 1 and 2, during normal delivery submitted to the application of low power laser versus "sham" laser: 1. Describe the biological characteristics (age, weight, height, BMI), sociodemographic (marital status, race, years studied, family income, social occupational); 2. Describe the characteristics related to life habits (smoking, activity physical, pelvic physiotherapy during pregnancy, Pilates during pregnancy, yoga during pregnancy); 3. Describe the previous gynecological and obstetric characteristics (number of pregnancies, type of previous births, number of abortions, suture in childbirth current) and obstetric (prenatal consultations, number of prenatal consultations, gestational age, gestational weight gain, use of oxytocin, use of analgesia, blood flow guidance, position during the second period of childbirth, hours labor, instrumental delivery, birth weight, head circumference of the newborn, shoulder dystocia, perineal laceration, the severity of lacerations, laceration extension, postpartum perineal pain); 4. Compare the parameters of REEDA, such as redness, edema, bruising, secretion and approximation of the edges at each intervention and in the range of seven and 42 days after laser application; 5. Compare the frequency of perineal pain and genito-pelvic pain at each intervention and between seven and 42 days after laser application; 6. Compare the measurement of the extent of perineal laceration, using Peri-Rule, the each intervention and in the interval of seven and 42 days after the application of the laser. Initially, the study will be carried out with 30 women (pilot study) for later the sample calculation will be carried out. A pilot study will be carried out, as, during the search in the database, no studies were found that address the use of low-level laser in spontaneous perineal lacerations, so that sample calculation was carried out. Randomization for the intervention and control groups will be performed according to a list of random numbers drawn up for that purpose by an employee who does not was involved with data collection, to ensure confidentiality in the allocation. From this list, sealed and opaque envelopes will be prepared, numbered sequentially, with each number, according to the randomization table, corresponds to the patient's allocation to the intervention or control group. For statistical analysis of the data, the domain statistical program will be used public Epi-info version 7, or higher versions. Tables will be distributed frequency distribution for categorical variables, calculating the mean and deviation standard of quantitative variables. Then, contingency tables will be used to determine the association of the independent variable (laser application) with the independent variables (REEDA scale, perineal pain, genito-pelvic pain). For determination of the strength of association will be calculated as a measure of the risk (RR) and its 95% confidence interval. All p values will be two-tailed and in all stages of the analysis will be considered a level of significance 5%.


Recruitment information / eligibility

Status Suspended
Enrollment 30
Est. completion date October 2024
Est. primary completion date February 2024
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Deliveries Assisted at the labor and delivery rooms (low risk) - Spontaneous perineal laceration (grades 1 and 2) - Primipara - Full-term pregnancy (37 to 41 weeks and six days) - Women over the age of 18 or under who are the presence of a responsible party - cephalic presentation - Single fetus - Admitted in labor Exclusion Criteria: - Transfer to another sector; - Performing an episiotomy; - Evolution to cesarean section; - Need for curettage; - Instrumental delivery (use of forceps and vacuum); - A patient who had the child referred to another sector; - Shoulder dystocia; - Change in skin sensitivity; - Presence of infection during childbirth care; - Postpartum hemorrhage; - Suspected or diagnosed with COVID-19

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
LASER
Laser will be applied in specific points for perineal lacerations.
CONTROL
A control group of sham laser will create for the patients the impression that laser is being played, with the lights of the instrument of "on mode" turned on, without biological effects.

Locations

Country Name City State
Brazil Maternidade Professor Barros Lima Recife Pernambuco

Sponsors (1)

Lead Sponsor Collaborator
Instituto Materno Infantil Prof. Fernando Figueira

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary SIZE OF LACERATION 6 hours after delivery Size in centimeters of the perineal laceration, measured by the PERI-RULE 6 hours after delivery 6 HOURS
Primary SIZE OF LACERATION 6 hours after delivery Size in centimeters of the perineal laceration, measured by the PERI-RULE 24 hours after delivery 24 hours after delivery
Primary SIZE OF LACERATION 6 hours after delivery Size in centimeters of the perineal laceration, measured by the PERI-RULE 48 hours after delivery 48 hours after delivery
Primary SIZE OF LACERATION AFTER ONE WEEK Size in centimeters of the perineal laceration, measured by the PERI-RULE one week after delivery 1 WEEK
Primary SIZE OF LACERATION AFTER 42 DAYS Size in centimeters of the perineal laceration, measured by the PERI-RULE after 42 days of delivery 42 DAYS
Secondary REDNESS AFTER 5 HOURS Redness evaluated with the REEDA (Redness, Oedema, Ecchymosis, Discharge, Approximation) scale with 6 hours after delivery The REEDA scale is a tool that assesses the inflammatory process and tissue healing in the perineal trauma, through the evaluation of five items of healing: redness (hyperaemia), oedema, ecchymosis, discharge and approximation of the wound edges (coaptation). For each assessed item, a score ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 6 hours after delivery
Secondary REDNESS AFTER 24 HOURS Redness evaluated with the REEDA scale with 24 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 24 hours after delivery
Secondary REDNESS AFTER 48 HOURS Redness evaluated with the REEDA scale with 48 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 48 hours after delivery
Secondary REDNESS AFTER 7 DAYS Redness evaluated with the REEDA scale with 7 DAYS of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 7 days
Secondary REDNESS AFTER 42 DAYS Redness evaluated with the REEDA scale with42 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 42 days
Secondary EDEMA AFTER 6 HOURS EDEMA evaluated with the REEDA scale with 6 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 6 hours after delivery
Secondary EDEMA AFTER 24 HOURS EDEMA evaluated with the REEDA scale with 24 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 24 hours after delivery
Secondary EDEMA AFTER 48 HOURS EDEMA evaluated with the REEDA scale with 48 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 48 hours after delivery
Secondary EDEMA AFTER 7 DAYS EDEMA evaluated with the REEDA scale with 7 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 7 days
Secondary EDEMA AFTER 42 DAYS EDEMA evaluated with the REEDA scale with 42 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 42 days
Secondary BRUISING AFTER 6 HOURS BRUISING evaluated with the REEDA scale with 6 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 6 hours after delivery
Secondary BRUISING FATER 24 HOURS BRUISING evaluated with the REEDA scale with 24 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 24 hours after delivery
Secondary BRUISING AFTER 48 HOURS BRUISING evaluated with the REEDA scale with 48 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 48 hours after delivery
Secondary BRUISING AFTER 7 DAYS BRUISING evaluated with the REEDA scale with 7 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 7 days
Secondary BRUISING AFTER 42 DAYS BRUISING evaluated with the REEDA scale with 42 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 42 days
Secondary PRESENCE OF SECRETION AFTER 6 HOURS PRESENCE OF SECRETION evaluated with the REEDA scale with 6 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma.
6 hours after delivery
Secondary PRESENCE OF SECRETION AFTER 24 HOURS PRESENCE OF SECRETION evaluated with the REEDA scale with 24 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma.
24 hours after delivery
Secondary PRESENCE OF SECRETION AFTER 48 HOURS PRESENCE OF SECRETION evaluated with the REEDA scale with 48 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma.
48 hours after delivery
Secondary PRESENCE OF SECRETION AFTER 7 DAYS PRESENCE OF SECRETION evaluated with the REEDA scale with 7 days of delivery 7 days
Secondary PRESENCE OF SECRETION AFTER 42 DAYS PRESENCE OF SECRETION evaluated with the REEDA scale with 42 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 42 days
Secondary WOUND CLOSURE AFTER 6 HOURS WOUND CLOSURE evaluated with the REEDA scale 6 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 6 hours after delivery
Secondary WOUND CLOSURE AFTER 24 HOURS WOUND CLOSURE evaluated with the REEDA scale 24 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 24 hours after delivery
Secondary WOUND CLOSURE AFTER 48 HOURS WOUND CLOSURE evaluated with the REEDA scale 48 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 48 hours after delivery
Secondary WOUND CLOSURE AFTER 7 DAYS WOUND CLOSURE evaluated with the REEDA scale with 7 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 7 days
Secondary WOUND CLOSURE AFTER 42 DAYS WOUND CLOSURE evaluated with the REEDA scale with 42 days of delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. 42 days
Secondary PERINEAL PAIN AFTER 6 HOURS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 6 hours of delivery (For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]) 6 hours of delivery
Secondary PERINEAL PAIN AFTER 24 HOURS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 24 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 24 hours of delivery
Secondary PERINEAL PAIN AFTER 48 HOURS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 48 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 48 hours of delivery
Secondary PERINEAL PAIN AFTER 7 DAYS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 7 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 7 days of delivery
Secondary PERINEAL PAIN AFTER 42 DAYS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 42 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 42 days of delivery
Secondary PELVIC PAIN AFTER 6 HOURS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 6 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 6 hours of delivery
Secondary PELVIC PAIN AFTER 24 HOURS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 24 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 24 hours of delivery
Secondary PELVIC PAIN AFTER 48 HOURS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 48 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 48 hours of delivery
Secondary PELVIC PAIN AFTER 7 DAYS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 7 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 7 days of delivery
Secondary PELVIC PAIN AFTER 42 DAYS PERINEAL PAIN evaluated with the Pain Visual Analog scale with 42 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale] 42 days of delivery
See also
  Status Clinical Trial Phase
Recruiting NCT05908292 - Optimizing Postpartum Pelvic Health Through Self-Scar Tissue Massage of Episiotomy and Perineal Scar Tissue A Pilot RCT N/A
Completed NCT03184077 - Rapidly Absorbing Polyglactin 910 Versus Poliglecaprone 25 for Laceration Repair N/A
Completed NCT03670420 - The Application of Honey on Perineal Sutures N/A
Completed NCT03039582 - Short Anovaginal Distance is Associated With Obstetric Anal Sphincter Rupture N/A
Recruiting NCT05935371 - Consequences of Obstetric Anal Sphincter Injuries on Maternal Psychology and Relationship Experience
Completed NCT03041779 - Comparison Between Rectal Suppository Acetaminophen and Diclofenac Sodium as Analgesia for Postpartum Perineal Tear Phase 2
Not yet recruiting NCT05556304 - In Vivo Evaluation of Perineal Mechanical Properties During Childbirth N/A
Recruiting NCT03983343 - Skin Glues Compared to Running Sutures for Perineal Skin Repair After Vaginal Delivery. A Randomized Controlled Trial N/A
Completed NCT01533467 - A Device Designed to Protect the Perineum During Labor Phase 2
Completed NCT03825211 - Continuous Versus Discontinuous Suture in the Perineals Lesions N/A
Completed NCT04860102 - Hands on vs Hands Off for Perineal Laceration N/A
Completed NCT03163160 - Electrolysis Technique vs Manual Therapy in Pelvic Pain N/A
Completed NCT05282160 - The Influence of Prepartum Perineal Training With the Epi-No Device on Pelvic Floor Function. N/A
Completed NCT05955352 - The Effect of Using Perineal Warm Compress Techniques During the Second Stage of Labor on Perineal Outcomes N/A
Completed NCT03559816 - Selective Use of Episiotomy: the Impact on Perineal Trauma.
Recruiting NCT04544488 - Descriptive Evaluation of Expulsive Efforts During Pregnancy in Term Nulliparous Women by Measurement of Intra Bladder Pressure: Pilot Observational Study. N/A
Completed NCT03770962 - One Plus One Equals Two, Will That do? N/A
Completed NCT05946005 - Lidocaine, Povidone Iodine, and Honey Application on Second-degree Perineal Tear Healing Phase 4
Completed NCT05962918 - Perineal Massage Performed During the Labour N/A
Completed NCT04370340 - Application of a Perineal Protection Device in Vacuum-assisted Births Phase 3